This topic contains a solution. Click here to go to the answer

Author Question: Breathing 100 O2, a patient has a PaO2PaO2 of 60 mm Hg. Based on this information, what might you ... (Read 9 times)

faduma

  • Hero Member
  • *****
  • Posts: 528
Breathing 100 O2, a patient has a PaO2PaO2 of 60 mm Hg. Based on this information, what might you conclude?
 
  a. The patient has severe hypoxemia.
  b. The patient has an excessive work of breathing.
  c. The patient has acceptable oxygenation.
  d. The patient has inadequate ventilation.

Question 2

You determine that an acutely ill patient can generate an MIP of 18 cm H2O. Based on this in-formation, what might you conclude?
 
  a. The patient has inadequate respiratory muscle strength.
  b. The patient has inadequate alveolar venti-lation.
  c. The patient has an excessive work of breathing.
  d. The patient has an unstable or irregular ventilatory drive.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ultraflyy23

  • Sr. Member
  • ****
  • Posts: 312
Answer to Question 1

ANS: C

Answer to Question 2

ANS: A




faduma

  • Member
  • Posts: 528
Reply 2 on: Jul 16, 2018
:D TYSM


chereeb

  • Member
  • Posts: 326
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

The average human gut is home to perhaps 500 to 1,000 different species of bacteria.

Did you know?

Excessive alcohol use costs the country approximately $235 billion every year.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

More than nineteen million Americans carry the factor V gene that causes blood clots, pulmonary embolism, and heart disease.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library